RAPT Therapeutics, Inc.
5 private offerings reported to the SEC on Form D since 2016, $317.0M sold in all. Biotech, CA.
- Form D offerings: 5
- Reported sold: $317.0M
- Newest: Jan 3, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Jan 3, 2025 | $150.0M | $150.0M | RAPT Therapeutics, Inc.Biotech · CA | Not amended | 0001673772-25-000001 |
| Jun 3, 2022 | $50.0M | $50.0M | RAPT Therapeutics, Inc.Biotech · CA | Not amended | 0001673772-22-000001 |
| Jan 2, 2019 | $37.1M | $67.1M | FLX Bio, Inc.Biotech · CA | Jun 20, 2019 | 0001673772-19-000001 |
| Jan 4, 2018 | $29.9M | $59.9M | FLX Bio, Inc.Biotech · CA | Not amended | 0001673772-18-000001 |
| May 5, 2016 | $50.0M | $50.0M | FLX Bio, Inc.Biotech · CA | Not amended | 0001673772-16-000001 |
SEC Profile
From the company's EDGAR record- Business address
- South San Francisco, Ca
- Incorporated in
- DE
- SEC industry
- Pharmaceutical Preparations
- Former names
- RAPT Therapeutics, Inc.; FLX Bio, Inc.
- All SEC filings
- CIK 1673772 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR